Testosterone Lawsuit – News

Prescription low-T Supplement Lawsuit News

Second U.S. jury finds AbbVie misrepresented risks of AndroGel

A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff’s lawyer said in a statement.

READ MORE at Reuters

AbbVie must pay $150 million over testosterone drug, jury decides

AbbVie must pay $150 million to an Oregon man who accused the pharmaceutical company of misrepresenting the safety risks of its AndroGel drug to treat low testosterone, a federal jury decided Monday in Chicago.

READ MORE at Chicago Tribune

With new testosterone data, AbbVie's AndroGel faces more questions about heart risks

AbbVie’s former blockbuster testosterone-replacement treatment AndroGel will be at the center of a class action lawsuit set to go to trial this year, alleging, in short, that previously healthy men suffered heart attacks and other side effects after taking the product.

READ MORE at FiercePharma


For a FREE, no-obligation case evaluation, call now at 877-539-1539 or complete our form.

Your name:
Your contact information
Best time to reach you:

*By submitting this form, I am granting permission to be contacted via phone, email, text or any other means. I am also confirming that I understand that no attorney-client relationship exists without a specific written retainer agreement between myself and a law firm.